Step 5 Lean Mass Preservation Protocol: GLP-1 class medications reduce appetite broadly ensuring adequate protein intake requires active attention to prevent lean mass loss alongside fat loss
For type 2 diabetes, the recommended starting dose of semaglutide is 0.25 mg once weekly
These fibres are metabolised by gut microbiota to produce short-chain fatty acids (SCFAs), including butyrate, propionate, and acetate, which directly stimulate L-cells to release GLP-1
If youre in this category and your results have plateaued before reaching your goal, its worth evaluating whether switching medications makes sense
Available: 100mg, 200mg, 500mg Metabolic Health Tirzepatide Dual GIP/GLP-1 receptor agonist representing the next generation of metabolic health therapeutics
These include detection of residual gastric contents, prokinetic agents, modification of anaesthesia, or deferral of procedure (see figure and explanatory notes)